Expert Analysis

Pooja Dodd and Arpan Banerjee from IP Gurus look into the differences between UK and Indian efforts in addressing groundless infringement threats

This year 12 people from the Asia-Pacific region made it into Managing IP’s list of the 50 people shaping the future of IP. Peter Ollier introduces their profiles

Ugur G Yalçiner and Irmak Yalçiner of Yalçiner Patent and Consulting look at the turning point in modern day Turkey’s industrial property system

Ramesh C Dhawan and Meetu Singh of Lall Lahiri & Salhotra provide an overview of the nuances and recent developments in Indian patent laws

Abhai Pandey and Kamakhya Srivastava of Lex Orbis IP Practice discuss how recent patent cases have built a body of precedent that will shape litigation for years to come

Welcome to the eighth edition of Managing IP's India Focus. We have a diverse selection of articles this year that shows the wide range of issues facing India's IP system. These vary from questions over software patents and the patentability of pharmaceutical products to missing files at the trade mark office and accession to the Madrid Protocol. As this supplement goes to press, a key case dealing with the patentability of Novartis's anti-cancer drug Glivec is being argued at the Supreme Court. Patent practitioners are hoping the judgment may finally shed some light on the notorious Section 3(d) of the country's Patent Act. And in the Monsoon session of Parliament India's politicians may pass far-reaching amendments to the country's Copyright Act.